Conroy Kevin T. - 25 Feb 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
01 Mar 2022, 17:22:46 UTC
Previous filing
25 Feb 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 915,396 25 Feb 2022 Direct F1
holding EXAS Common Stock 26,574 25 Feb 2022 Held in 401(k) Plan
holding EXAS Common Stock 21,730 25 Feb 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,730 25 Feb 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,729 25 Feb 2022 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Award $0 +52,722 $0.000000 52,722 25 Feb 2022 Common Stock 52,722 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to the shares of Common Stock reported on this Form 4, which total 1,007,159 shares, Mr. Conroy also holds, in the aggregate, an additional 1,027,950 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.